Sex differences in spontaneous versus induced animal models of autoimmunity

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Lee, Tai Ping ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Animal model; Hormone therapy; Human autoimmune diseases; Sex differences; Sex hormones

Indexed keywords

ANDROGEN; AUTOANTIGEN; CHORIONIC GONADOTROPIN; ESTRADIOL; ESTROGEN; NAFOXIDINE; PROGESTERONE; PROLACTIN; RALOXIFENE; SEX HORMONE; TESTOSTERONE;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTING CELL; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; COLLAGEN INDUCED ARTHRITIS; HASHIMOTO DISEASE; HORMONAL THERAPY; HUMAN; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; REVIEW; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MACROPHAGES; MALE; MICE; PROGESTERONE; SEX FACTORS; T-LYMPHOCYTES;

EID: 84858441796     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.020     Document Type: Review

References (129)

1. Brooks W.H. X-chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol 2010, 39(1):20-29.
2. Cooper G.S., Stroehla B.C. The epidemiology of autoimmune diseases. Autoimmun Rev 2003, 2:119-125.
3. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780.
4. Rubtsov A.V., Rubtsova K., Kappler J.W., Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 2010, 9(7):494-498.
5. Libert C., Dejager L., Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 2010, 10(8):594-604.
6. Ozcelik T., Uz E., Akyerli C.B., Bagislar S., Mustafa C.A., Gursoy A., et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 2006, 14:791-797.
7. Uz E., Loubiere L.S., Gadi V.K., Ozbalkan Z., Stewart J., Nelson J.L., et al. Skewed X-chromosome inactivation in scleroderma. Clin Rev Allergy Immunol 2008, 34:352-355.
8. Stewart J.J. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 1998, 19:352-357.
9. Scofield R.H., Bruner G.R., Namjou B., Kimberly R.P., Ramsey-Goldman R., Petri M., et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008, 58:2511-2517.
10. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33:12-16.
11. Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 2009, 33:1-2.
12. Invernizzi P., Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 2009, 33(3-4):290-299.
13. Invernizzi P., Miozzo M., Selmi C., Persani L., Battezzati P.M., Zuin M., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005, 175:575-578.
14. Nussinovitch U., Shoenfeld Y. The role of gender and organ specific autoimmunity. Autoimmun Rev Nov 7. 2011, [Epub ahead of print].
15. Fairweather D., Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 2009, 33(3-4):222-230.
16. Quintero O.L., Amador-Patarroyo M.J., Montoya-Ortiz G., Rojas-Villarraga A., Anaya J.M. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun Nov. 11, 2011, [Epub ahead of print].
17. Cutolo M., Sulli A., Seriolo S., Accardo S., Masi A.T. Estrogens, the immune response, and autoimmunity. Clin Exp Rheumatol 1995, 13:217-226.
18. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science 1999, 283:1277-1278.
19. McCarthy M. The "gender gap" in autoimmune disease. Lancet 2000, 356:1088.
20. Gleicher N., Weiner R., Vietzke M. The impact of abnormal autoimmune function on reproduction: maternal and fetal consequences. J Autoimmun 2006, 27:161-165.
21. Morel L. Mouse models of human autoimmune diseases: that require the proper controls. PLoS Biol 2004, 2(8):E241.
22. Voskuhl R. Sex differences in autoimmune diseases. Biol Sex Differ 2011, 2:1.
23. Tsai B.Y., Lin Y.L., Chiang B.L. Autoimmune response induced by dendritic cells exerts anti-tumor effect in murine model of leukemia. J Autoimmun 2010, 49:34-42.
24. Papenfuss T.L., Powell N.D., McClain M.A., Bedarf A., Singh A., Gienapp I.E., et al. Estriol generstes tolerogenic dendritic cells in vivo that protect against autoimmunity. J Immunol 2011, 186:3346-3355.
25. Escribese M.M., Rodriguez-Garcia M., Sperling R., Engel S.M., Gallart T., Moran T.M. Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen. Reprod Biol Endocrinol 2011, 9:118-129.
26. Hughes G., Clark E. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 2007, 40:470-481.
27. Nalbandian G., Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 2005, 31(2):91-106.
28. Kramer P.R., Kramer S.F., Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004, 50(6):1967-1975.
29. Mor G., Sapi E., Abrahams V.M., Rutherford T., Song J., Hao X.Y., et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 2003, 170(1):114-122.
30. Bouman A., Moes H., Heineman M.J., de Leij L.F., Faas M.M. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Fertil Steril 2001, 76(3):555-559.
31. Brannstrom M., Friden B.E., Jasper M., Norman R.J. Variations in peripheral blood levels of immuno-reactive tumor necrosis factor alpha (TNF-alpha) throughout the menstrual cycle and secretion of TNF-alpha from the human corpus luteum. Eur J Obstet Gynecol Reprod Biol 1999, 83(2):213-217.
32. Polan M.L., Loukides J.A., Honig J. Interleukin-1 in human ovarian cells and in peripheral blood monocytes increases during the luteal phase: evidence for a mid-cycle surge in the human. Am J Obstet Gynecol 1994, 170(4):1000-1006.
33. Posma E., Moes H., Heineman M.J., Faas M. The effect of testosterone on cytokine production in the specific and non-specific immune response. Am J Reprod Immunol 2004, 52:237-243.
34. Verthelyi D. Sex hormones as immuno-modulators in health and disease. Int Immunopharmacol 2001, 1:983-993.
35. Bouman A., Heineman M.J., Faas M.M. Sex hormones and the immune response in humans. Hum Reprod Update 2005, 11(4):411-423.
36. Kim W.U., Min S.Y., Hwang S.H., Yoo S.A., Kim K.J., Cho C.S. Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus. Clin Exp Immunol 2010, 161:453-458.
37. Menard D., Mandeng M.J., Tothy M.B., Kelembho E.K., Gresenguet G., Talarmin A. Immuno-hematological reference ranges for adults from the Central African Republic. Clin Diagn Lab Immunol 2003, 10(3):443-445.
38. Ahmed S.A., Hissong B.D., Verthelyi D., Donner K., Becker K., Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect 1999, 107(Suppl. 5):681-686.
39. Luo C.Y., Wang L., Sun C., Li D.J. Estrogen enhances the functions of CD4+ CD25+ Foxp-3+ regulatory T cells that suppress osteoclast differentiation and bone resorption in vivo. Cell Mol Immunol 2011, 8:50-58.
40. Lélu K., Laffont S., Delpy L., Paulet P.E., Périnat T., Tschanz S.A., et al. Estrogen receptor a signaling in T lymphocytes is required for estradiol-mediated Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol 2011, 187:2386-2393.
41. Bekesi G., Tulassay Z., Racz K., Feher J., Szekacs B., Kakucs R., et al. The effect of estrogens on superoxide anion generation by human neutrophil granulocytes: possible consequences of the antioxidant defense. Gynecol Endocrinol 2007, 23(8):451-454.
42. Geraldes P., Gagnon S., Hadjadj S., Merhi Y., Sirois M.G., Cloutier I., et al. Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERalpha-mediated pathway. Cardiovasc Res 2006, 71(3):566-573.
43. Josefsson E., Tarkowski A., Carlsten H. Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992, 142(1):67-78.
44. Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 2007, 28:1-6.
45. González D.A., Díaz B.B., Rodríguez Pérez Mdel C., Hernández A.G., Chico B.N., de León A.C. Sex hormones and autoimmunity. Immunol Lett 2010, 133:6-13.
46. Grimaldi C.M., Cleary J., Dagtas A.S., Moussai D., Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002, 109:1625-1633.
47. Kanda N., Tsuchida T., Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:1703-1711.
48. Kanda N., Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999, 103:282-288.
49. Verthelyi D., Ansar Ahmed S. Estrogen increases the number of plasma cells and enhances their auto-antibody production in non-autoimmune C57BL/6 mice. Cell Immunol 1998, 189:125-134.
50. Verthelyi D., Ansar Ahmed S. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. J Autoimmun 1997, 10:115-125.
51. Cohen-Solal J.F., Jeganathan V., Grimaldi C.M., Peeva E., Diamond B. Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol 2006, 305:67-88.
52. Ansar Ahmed S., Verthelyi D. Antibodies to cardiolipin in normal C57BL/6: induction by estrogen but not dihydrotestosterone. J Autoimmun 1993, 6:265-269.
53. McMurray R.W. Estrogen, prolactin, and autoimmunity: actions and interactions. Int Immunopharmacol 2001, 1:995-1008.
54. Cutolo M., Wilder R. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am 2000, 26:825-839.
55. McMurray R., Keisler D., Kanuckel K., Izui S., Walker S.E. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991, 147:3780-3787.
56. Orbach H., Shoenfeld Y. Hyper-prolactinemia and autoimmune diseases. Autoimmun Rev 2007, 6:537-542.
57. Beageley K.W., Gockel C.M. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003, 38:13-22.
58. Dinesh R.K., Hahn B.H., Singh R.P. PD-1, gender, and autoimmunity. Autoimmun Rev 2010, 9:583-587.
59. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Seriolo B., et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13:635-638.
60. Yacoub Wasef S.Z. Gender differences in systemic lupus erythematosus. Gend Med 2004, 1:12-17.
61. Grimaldi C.M., Hill L., Xu X., Peeva E., Diamond B. Hormonal modulation of B cell development and repertoire selection. Mol Immunol 2005, 42:811-820.
62. Rider V., Abdou N. Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 2001, 1:1009-1024.
63. Jara L., Benitez G., Medina G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev 2008, 7:251-255.
64. Kouskoff V., Korganow A.S., Duchatelle V., Degott C., Benoist C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996, 87:811-822.
65. Cutolo M., Montagna P., Brizzolara R., Sulli A., Seriolo B., Villaggio B., et al. Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients. J Autoimmun 2009, 32(3-4):254-260.
66. Wilder R.L. Hormones and autoimmunity: animal models of arthritis. Baillieres Clin Rheumatol 1996, 10:259-271.
67. Cejkova P., Fojtikova M., Cerna M. Immuno-modulatory role of prolactin in diabetes development. Autoimmun Rev 2009, 9:23-27.
68. Delpy L., Douin-Echinard V., Garidou L., Bruand C., Saoudi A., Guery J.C. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J Immunol 2005, 175:5050-5057.
69. Zandman-Goddard G., Peeva E., Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007, 6:366-372.
70. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 2008, 7:626-630.
71. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
72. Isse K., Specht S.M., Lunz J.G., Kang L.I., Mizuguchi Y., Demetris A.J. Estrogen stimulates female biliary epithelial cell interleukin-6 expression in mice and humans. Hepatology 2010, 51:869-880.
73. Gaillard R.C., Spinedi E. Sex- and stress-steroids interactions and the immune system: evidence for a neuroendocrine-immunological sexual dimorphism. Domest Anim Endocrinol 1998, 15:345-352.
74. Kanda N., Tsuchida T., Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999, 42:328-337.
75. Bynoe M.S., Grimaldi C.M., Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci U S A 2000, 97:2703-2708.
76. Grimaldi C.M., Michael D.J., Diamond B. Cutting edge: expansion and activation of a population of auto-reactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001, 167:1886-1890.
77. Carlsten H., Nilsson N., Jonsson R., Bäckman K., Holmdahl R., Tarkowski A. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol 1992, 144:190-202.
78. McCarty D.J., Manzi S., Medsger T.A., Ramsey-Goldman R., LaPorte R.E., Kwoh C.K. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995, 38:1260-1270.
79. Cunningham M., Gilkeson G. Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 2011, 40:66-73.
80. Apelgren L.D., Bailey D.L., Fouts R.L., Short L., Bryan N., Evans G.F., et al. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell Immunol 1996, 173:55-63.
81. Wu W.M., Suen J.L., Lin B.F., Chiang B.L. Tamoxifen alleviates disease severity and decrease double negative T cells in autoimmune MRLlpr/lpr mice. Immunology 2000, 100:110-118.
82. Wu W.M., Lin B.F., Su Y.C., Suen J.L., Chiang B.L. Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice. Scand J Immunol 2000, 52:393-400.
83. Li J., McMurray R.W. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin Immunol 2007, 123(2):219-226.
84. Carlsten H., Tarkowski A., Holmdahl R., Nilsson L.A. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol 1990, 80:467-473.
85. Ruiz-Irastorza G., Lima F., Alves J., Khamashta M.A., Simpson J., Hughes G.R., et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996, 35:133-138.
86. Petri M., Howard D., Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991, 34:1538-1545.
87. Smith D.L., Dong X., Du S., Oh M., Singh R.R., Voskuhl R.R. A female preponderance for chemically induced lupus in SJL/J mice. Clin Immunol 2007, 122:101-107.
88. Perry D., Sang A., Yin Y., Zheng Y.Y., Morel L. Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011, 2011:271694. Epub 2011 Feb 14.
89. Layer T., Steele A., Goeken J.A., Fleenor S., Lenert P. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor -7 agonist and antagonists in BXSB mice. Clin Exp Immunol 2011, 163:392-403.
90. Shen N., Fu Q., Deng Y., Qian X., Zhao J., Kaufman K.M., et al. Sex-sepcific association of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A 2010, 107:15838-15843.
91. Bubier J.A., Sprouie T.J., Foreman O., Spolski R., Shaffer D.J., Morse H.C., et al. Acritical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A 2009, 106:1518-1523.
92. Ostman J., Lonnberg G., Arnqvist H.J., Blohme G., Bolinder J., Ekbom S.A., et al. Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002. J Intern Med 2008, 263:386-394.
93. Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., Mortensen P.B. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007, 29:1-9.
94. Ezaki T., Fujii H., Matsuno K., Kawatsu R., Kotani M. Oestrogen retards the development of spontaneous thymomas in BUF/Mna rats. Virchows Arch A Pathol Anat Histopathol 1992, 421:505-511.
95. Fox H.S. Androgen treatment prevents diabetes in non-obese diabetic mice. J Exp Med 1992, 175:1409-1412.
96. Fitzpatrick F., Lepault F., Homo-Delarche F., Bach J.F., Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the non-obese diabetic mouse. Endocrinology 1991, 129:1382-1390.
97. Verheul H.A., Verveld M., Hoefakker S., Schuurs A.H. Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD mice. Immunopharmacol Immunotoxicol 1995, 17:163-180.
98. Sato E.H., Sullivan D.A. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren's syndrome. Invest Ophthalmol Vis Sci 1994, 35:2632-2642.
99. Irie J., Wu Y., Wicker L.S., Rainbow D., Nalesnik M.A., Hirsch R., et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006, 203:1209-1219.
100. Tsuneyama K., Moritoki Y., Kikuchi K., Nakanuma Y. Pathological features of new animal models for primary biliary cirrhosis. Int J Hepatol 2012, 2012. 403954 [Epub 2011 Jul 6].
101. Koarada S., Wu Y., Fertig N., Sass D.A., Nalesnik M., Todd J.A., et al. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a non-obese diabetic congenic strain. J Immunol 2004, 173:2315-2323.
102. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005, 42:1194-1202.
103. Krassas G.E., Tziomalos K., Pontikides N., Lewy H., Laron Z. Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population. Eur J Endocrinol 2007, 156:631-636.
104. McCombe P.A., Greer J.M., Mackay I.R. Sexual dimorphism in autoimmune disease. Curr Mol Med 2009, 9(9):1058-1079.
105. Jansson L., Olsson T., Holmdahl R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol 1994, 53:203-207.
106. Latham K.A., Zamora A., Drought H., Subramanian S., Matejuk A., Offner H., et al. Estradiol treatment redirects the isotype of the autoantibody response and prevents the development of autoimmune arthritis. J Immunol 2003, 171:5820-5827.
107. Bebo B.F., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 2001, 166:2080-2089.
108. Ito A., Bebo B.F., Matejuk A., Zamora A., Silverman M., Fyfe-Johnson A., et al. Estrogen treatment down-regulates TNF-production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 2001, 167:529-542.
109. Jansson L., Mattsson A., Mattsson R., Holmdahl R. Estrogen induced suppression of collagen arthritis. V: Physiological levels of estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-type II collagen T cell mediated immunity and stimulates polyclonal B cell activity. J Autoimmun 1990, 3:257-270.
110. Gonzalez A., Maradit K.H., Crowson C.S., Nicola P.J., Davis J.M., Therneau T.M., et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007, 56:3583-3587.
111. Ganesan K., Selvam R., Abhirami R., Raju K.V., Manohar B.M., Puvanakrishnan R. Gender differences and protective effects of testosterone in collagen induced arthritis in rats. Rheumatol Int 2008, 28:345-353.
112. de Man Y.A., Dolhain R.J., van de Geijn F.E., Willemsen S.P., Hazes J.M. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 2008, 59:1241-1248.
113. Huang C.M., Yang Y.H., Chiang B.L. Different familial association patterns of autoimmune diseases between juvenile-onset systemic lupus erythematosus and juvenile rheumatoid arthritis. J Microbiol Immunol Infect 2004, 37:88-94.
114. Huang J.L., Yao T.C., See L.C. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 2004, 22:776-780.
115. Kristensen K.D., Stoustrup P., Küseler A., Pedersen T.K., Nyengaard J.R., Hauge E.M., et al. Quantitative histological changes of repeated antigen-induced arthritis in the temporo-mandibular joints of rabbits treated with intra-articular corticosteroid. J Oral Pathol Med 2008, 37:437-444.
116. Kapila S., Lee C., Tavakkoli Jou M.R., Miller A.J., Richards D.W. Development and histologic characterizations of an animal model of antigen-induced arthritis of the juvenile rabbit temporo-mandibular joint. J Dent Res 1995, 74:1870-1879.
117. McMurray R.W., Allen S.H., Pepmueller P.H., Keisler D., Cassidy J.T. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and anti-nuclear antibody sero-positivity. J Rheumatol 1995, 22:1577-1580.
118. Khalkhali-Ellis Z., Moore T.L., Hendrix M.J. Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity. Clin Exp Rheumatol 1998, 16:753-756.
119. Hirst C., Ingram G., Pickersgill T., Swingler R., Compston D.A., Robertson N.P. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009, 80(4):386-391.
120. Orton S.M., Herrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnick A.D., et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006, 5:932-936.
121. Voskuhl R.R., Pitchekian-Halabi H., MacKenzie-Graham A., McFarland H.F., Raine C.S. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 1996, 39:724-733.
122. Gold S.M., Voskuhl R.R. Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 2009, 175:239-251.
123. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998, 339:285-291.
124. Yates M.A., Li Y., Chlebeck P., Proctor T., Vandenbark A.A., Offner H. Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol 2010, 220:136-139.
125. Costenbader K.H., Gay S., Riquelme M.E., Iaccarino L., Doria A. Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases?. Autoimmun Rev Oct 25, 2011, [Epub ahead of print].
126. Villaverde-Hueso A., Sánchez-Valle E., Alvarez E., Morant C., Carreira P.E., Martín-Arribas M.C., et al. Estimating the burden of scleroderma disease in Spain. J Rheumatol 2007, 34:2236-2242.
127. Ahmed S.A., Talal N. Sex hormones and the immune system--Part 2. Animal data. Baillieres Clin Rheumatol 1990, 4:13-31.
128. Santora K., Rasa C., Visco D., Steinetz B.G., Bagnell C.A. Anti-arthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis. J Pharmacol Exp Ther 2007, 322:887-893.
129. Mirone L., Barini A., Barini A. Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity. Ann N Y Acad Sci 2006, 1069:257-262.